Immune‐mediated thrombotic thrombocytopenic purpura in a Jehovah’s Witness – Effectiveness of incorporating extracorporeal immunoadsorption to caplacizumab, steroids and rituximab
- Resource Type
- article
- Source
- Clinical Case Reports, Vol 10, Iss 5, Pp n/a-n/a (2022)
- Subject
caplacizumab immune‐mediated TTP – SARS‐Cov2 immunoadsorption Jehovah's Witness therapy without therapeutic plasma exchange Medicine Medicine (General) R5-920 - Language
- English
- ISSN
- 2050-0904